Authors: Dinndorf, P Krailo, M Liu-Mares, W Frierdich, S Sondel, P Reaman, G

Citation: P. Dinndorf et al., Phase I trial of anti-B4-blocked ricin in pediatric patients with leukemiaand lymphoma, J IMMUNOTH, 24(6), 2001, pp. 511-516

Authors: Bracho, F Krailo, MD Shen, V Bergeron, S Davenport, V Liu-Mares, W Blazar, BR Panoskaltsis-Mortari, A van de Ven, C Secola, R Ames, MM Reid, JM Reaman, GH Cairo, MS

Citation: F. Bracho et al., A phase I clinical, pharmacological, and biological trial of interleukin 6plus granulocyte-colony stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent/refractory solid tumors: Enhanced hematological responses but a high incidence of grade III/IV constitutionaltoxicities, CLIN CANC R, 7(1), 2001, pp. 58-67

Authors: Cairo, MS Shen, V Krailo, MD Bauer, M Miser, JS Sato, JK Blatt, J Blazar, BR Frierdich, S Liu-Mares, W Reaman, GH

Citation: Ms. Cairo et al., Prospective randomized trial between two doses of granulocyte colony-stimulating factor after ifosfamide, carboplatin, and etoposide in children withrecurrent or refractory solid tumors: A Children's Cancer Group report, J PED H ONC, 23(1), 2001, pp. 30-38

Authors: Meyers, PA Krailo, MD Ladanyi, M Chan, KW Sailer, SL Dickman, PS Baker, DL Davis, JH Gerbing, RB Grovas, A Herzog, CE Lindsley, KL Liu-Mares, W Nachman, JB Sieger, L Wadman, J Gorlick, RG

Citation: Pa. Meyers et al., High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis, J CL ONCOL, 19(11), 2001, pp. 2812-2820

Authors: Ortega, JA Douglass, EC Feusner, JH Reynolds, M Quinn, JJ Finegold, MJ Haas, JE King, DR Liu-Mares, W Sensel, MG Krailo, MD

Citation: Ja. Ortega et al., Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group, J CL ONCOL, 18(14), 2000, pp. 2665-2675

Authors: Heerema, NA Sather, HN Sensel, MG Liu-Mares, W Lange, BJ Bostrom, BC Nachman, JB Steinherz, PG Hutchinson, R Gaynon, PS Arthur, DC Uckun, FM

Citation: Na. Heerema et al., Association of chromosome arm 9p abnormalities with adverse risk in childhood acute lymphoblastic leukemia: A report from the Children's Cancer Group, BLOOD, 94(5), 1999, pp. 1537-1544